Surgery Partners (SGRY) Shares Outstanding (2014 - 2026)

Surgery Partners has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $130.8 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 2.03% year-over-year to $130.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $130.8 million (up 2.03% YoY) and the FY2025 annual result came in at $129.3 million, up 1.74% from the prior year.
• Shares Outstanding (Entity) rose to $130.8 million in Q1 2026 per SGRY's latest filing, from $129.3 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $130.8 million in Q1 2026 and troughed at $89.9 million in Q1 2022.
• A 5-year average of $118.9 million and a median of $127.1 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) jumped 50.09% in 2022, then rose 0.41% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $92.0 million in 2022, then soared by 37.67% to $126.6 million in 2023, then increased by 0.41% to $127.1 million in 2024, then advanced by 1.74% to $129.3 million in 2025, then climbed by 1.14% to $130.8 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $130.8 million, $129.3 million, and $129.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.